These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 18752084)
1. Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976-2005. Kemetli L; Rutqvist LE; Jonsson H; Nyström L; Lenner P; Törnberg S Acta Oncol; 2009; 48(1):59-66. PubMed ID: 18752084 [TBL] [Abstract][Full Text] [Related]
2. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy. Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O; Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568 [TBL] [Abstract][Full Text] [Related]
3. Estimating the benefits of adjuvant systemic therapy for women with early breast cancer. Grogan M; Tabar L; Chua B; Chen HH; Boyages J Br J Surg; 2001 Nov; 88(11):1513-8. PubMed ID: 11683751 [TBL] [Abstract][Full Text] [Related]
4. [Determining factors for adjuvant treatment of breast cancer in the Côte d'Or region 1982-1990. Registry of gynecologic cancers at the Côte d'Or]. Coudert B; Chaplain G; Milan C; Janoray P Bull Cancer; 1996 Jan; 83(1):54-62. PubMed ID: 8672857 [TBL] [Abstract][Full Text] [Related]
5. [Questions and answers on adjuvant systemic therapy in breast carcinoma]. Fey MF; Castiglione-Gertsch M Ther Umsch; 1996 Nov; 53(11):839-46. PubMed ID: 8984689 [TBL] [Abstract][Full Text] [Related]
6. Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands. Sukel MP; van de Poll-Franse LV; Nieuwenhuijzen GA; Vreugdenhil G; Herings RM; Coebergh JW; Voogd AC Eur J Cancer; 2008 Sep; 44(13):1846-54. PubMed ID: 18640030 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Sverrisdottir A; Nystedt M; Johansson H; Fornander T Breast Cancer Res Treat; 2009 Oct; 117(3):561-7. PubMed ID: 19153828 [TBL] [Abstract][Full Text] [Related]
8. Changing practice in systemic breast cancer adjuvant treatment in a well-defined French population. Chaplain G; Coudert B; Milan C; Altwegg T; Esteve J Bull Cancer; 1999 Oct; 86(10):855-60. PubMed ID: 10572236 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer and aging. Stewart JA; Foster RS Semin Oncol; 1989 Feb; 16(1):41-50. PubMed ID: 2645649 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists. Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441 [TBL] [Abstract][Full Text] [Related]
11. The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy. Zhang Y; Sieuwerts AM; McGreevy M; Casey G; Cufer T; Paradiso A; Harbeck N; Span PN; Hicks DG; Crowe J; Tubbs RR; Budd GT; Lyons J; Sweep FC; Schmitt M; Schittulli F; Golouh R; Talantov D; Wang Y; Foekens JA Breast Cancer Res Treat; 2009 Jul; 116(2):303-9. PubMed ID: 18821012 [TBL] [Abstract][Full Text] [Related]
12. Elderly breast cancer patients: adjuvant chemotherapy and adjuvant endocrine therapy. Biganzoli L; Aapro M Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):137-42. PubMed ID: 15990438 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant endocrine therapy for perimenopausal women with early breast cancer. Ortmann O; Cufer T; Dixon JM; Maass N; Marchetti P; Pagani O; Pronzato P; Semiglazov V; Spano JP; Vrdoljak E; Wildiers H Breast; 2009 Feb; 18(1):2-7. PubMed ID: 19036588 [TBL] [Abstract][Full Text] [Related]
14. Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial. Alkner S; Bendahl PO; Fernö M; Nordenskjöld B; Rydén L; Eur J Cancer; 2009 Sep; 45(14):2496-502. PubMed ID: 19535242 [TBL] [Abstract][Full Text] [Related]
15. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621 [TBL] [Abstract][Full Text] [Related]
16. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer patients' experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET). Malinovszky KM; Cameron D; Douglas S; Love C; Leonard T; Dixon JM; Hopwood P; Leonard RC Breast; 2004 Oct; 13(5):363-8. PubMed ID: 15454190 [TBL] [Abstract][Full Text] [Related]
18. Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer. Chlebowski RT Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():25-34. PubMed ID: 19101792 [TBL] [Abstract][Full Text] [Related]
19. [Early-stage breast cancer - strategies for adjuvant systemic therapy]. Görner M; Just M; Gerull S Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990 [TBL] [Abstract][Full Text] [Related]
20. [Postoperative changes in serum lipid levels of breast cancer and adjuvant chemotherapy]. Morimoto K; Koh M Gan To Kagaku Ryoho; 2004 Oct; 31(10):1517-24. PubMed ID: 15508443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]